Veterinary Medicines

Rispoval Pasteurella, lyofilisaat en suspendeervloeistof voor emulsie voor injectie voor runderen

Authorised
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Download as PDF

Product identification

Medicine name:
Rispoval Pasteurella, lyofilisaat en suspendeervloeistof voor emulsie voor injectie voor runderen
Active substance:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
    200.00
    relative unit(s)
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
    345.00
    relative unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 5 doses of vaccine and solvent in glass vials (type I) with a rubber stopper and an aluminum cap (1 dose of 2 ml)
  • 25 doses of vaccine and solvent in glass vials (type I) with a rubber stopper and an aluminum cap (1 dose of 2 ml)
  • 1 dose of vaccine and solvent in glass vials (type I) with a rubber stopper and an aluminum cap (1 dose of 2 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8661
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 1/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."